BioNTech | Modern manufacturing processes for the production …
WEBWe have several manufacturing sites capable of developing fully automated production processes for on-demand production of our therapies and vaccines. In addition, we have developed a shippable, modular and turnkey mRNA manufacturing facility, called BioNTainer, to support a decentralized and scalable …
BioNTech
WEBOur mission. We are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies. We believe in scientific rigor, innovation and passion as driving force.
BioNTech - Wikipedia
WEBBioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
Pfizer–BioNTech COVID-19 vaccine - Wikipedia
WEBPfizer and BioNTech are manufacturing the vaccine in their own facilities in the United States and in Europe. The license to distribute and manufacture the vaccine in China was purchased by Fosun, alongside its investment in BioNTech.
Pfizer and BioNTech Announce Further Details on …
WEBApr 9, 2020 · Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supply
All BioNTech locations at a glance
WEBOur Production Network. We are constantly expanding our global manufacturing network to produce innovative immunotherapies and strive to ensure equitable access to our programs. From Mainz out into the world. Discover BioNTech's global network and find all contact information for our locations.
Statement on Manufacturing - BioNTech
WEBFeb 1, 2021 · In order to respond to an increased global demand, we plan to manufacture two billion doses of our COVID-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50%. We are on track to scale-up our manufacturing capacities.
Additional manufacturing capacity for BioNTech/Pfizer’s COVID …
WEBJun 1, 2021 · Based on the review of the data submitted by BioNTech Manufacturing GmbH, EMA’s decision reaffirms that the Puurs facility is capable of consistently producing high-quality vaccines and enables Pfizer/BioNTech to increase the volumes of vaccines produced at this site.
Inside BioNTech's Factory Where Pfizer Vaccine Is Made | TIME
WEBApr 19, 2021 · The German biotech company, co-founded by a husband-and-wife team of scientists, developed the vaccine that became not only the first to earn authorization in the U.S. for COVID-19 in December but...
BioNTech to Acquire GMP Manufacturing Site to Expand COVID …
WEBSep 17, 2020 · Facility will become one of the largest mRNA manufacturing sites in Europe and the third site in the BioNTech manufacturing network in Germany expected to produce BNT162 for global supply; Expected to be fully operational in the first half 2021 with an annual production capacity up to 750 million doses of potential COVID-19 vaccine
Skip to content